Abstract
The aims of this study were to investigate the main clinical and laboratory features, including pregnancy and genetic analysis, of Turkish Familial Mediterranean Fever (FMF) patients and to analyze the relationships between genotypic features, age of disease onset, clinical findings, and disease severity. A study was planned within a national network of 22 different centers. Demographics, clinical and laboratory findings, attack characteristics, drugs, pregnancy and birth history, disease severity, and gene mutation analyses were evaluated. Disease severity, assessed using a scoring system developed by Pras et al., was evaluated in relation to gene mutations and age of disease onset. A total of 979 patients (643 females and 336 males; mean age: 35.92 ± 11.97 years) with FMF were included in the study. Of a total of 585 pregnancies, 7% of them resulted in preterm birth and 18.1% resulted in abortions. During pregnancy, there was no FMF attack in 61.4% of patients. Of the MEditerranean FeVer (MEFV) mutations, 150 (24.3%) cases were homozygous, 292 (47.3%) cases were heterozygous, and 175 (28.4%) were compound heterozygous. Patients with homozygous gene mutations had more severe disease activity, earlier age of disease onset, higher rates of joint and skin involvement, sacroiliitis, and amyloidosis. Patients with compound heterozygous genotype displayed severe disease activity in close resemblance to patients with homozygous mutation. In addition, patients with compound heterozygous mutations had higher rates of protracted febrile myalgia and elevated fibrinogen levels. In 63.9% of compound heterozygous patients, age of onset was < 20 years, with greater disease severity, and high rates of attack frequency and colchicine resistance. Our results suggest that indicators for disease severity include early onset of disease and homozygous gene mutations. Furthermore, patients with compound heterozygous mutations displayed significant presentations of severe disease activity.
Similar content being viewed by others
References
Beheshtian M, Izadi N, Kriegshauser G, Kahrizi K, Mehr EP, Rostami M, Hosseini M, Azad M, Montajabiniat M, Kariminejad A, Nemeth S, Oberkanins C, Najmabadi H (2016) Prevalence of common MEFV mutations and carrier frequencies in a large cohort of Iranian populations. J Genet 95:667–674
Özen S (2018) Update on the epidemiology and disease outcome of Familial Mediterranean fever. Best Pract Res Clin Rheumatol 32:254–260. https://doi.org/10.1016/j.berh.2018.09.003
Arıcı SA, Bilginer Y, Özen S (2017) Familial mediterranean fever: epidemyology and genetics. J Rheumatol-Special 10:1–7 (Turkiye Klinikleri)
Ozdogan H, Ugurlu S (2019) Familial mediterranean fever. Presse Med. https://doi.org/10.1016/j.lpm.2018.08.014
Shahbaznejad L, Raeeskarami SR, Assari R, Shakoori A, Azhideh H, Aghighi Y, Tahghighi F, Ziaee V (2018) Familial mediterranean gene (MEFV) mutation in parents of children with familial mediterranean fever: what are the exceptions? Int J Inflam 2018:1902791. https://doi.org/10.1155/2018/1902791
Üreten K (2017) Familial Mediterranean Fever: Clinical Manifestations. J Rheumatol-Special 10:13–18 (Turkiye Klinikleri)
Akar S, Solmaz D, Kasifoglu T, Bilge SY, Sari I, Gumus ZZ, Tunca M (2016) Different disease subtypes with distinct clinical expression in familial Mediterranean fever: results of a cluster analysis. Rheumatology (Oxford) 55:343–346
Güncan S, Bilge NŞ, Cansu DÜ, Kaşifoğlu T, Korkmaz C (2016) The role of MEFV mutations in the concurrent disorders observed in patients with familial Mediterranean fever. Eur J Rheumatol 3:118–121
Cetin GY, Balkarli A, Öksüz AN, Kimyon G, Pehlivan Y, Orhan O, Kisacik B, Cobankara V, Sayarlioglu H, Onat AM, Sayarlioglu M (2014) Evaluation of frequency and the attacks features of patients with colchicine resistance in FMF. Rev Bras Reumatol. 54:356–359
Endo Y, Koga T, Ishida M, Fujita Y, Tsuji S, Takatani A (2018) Musculoskeletal manifestations occur predominantly in patients with later-onset familial Mediterranean fever: data from a multicenter, prospective national cohort study in Japan. Arthritis Res Ther 20:257. https://doi.org/10.1186/s13075-018-1738-1
Aydın F, Özçakar ZB, Yalçınkaya F (2017) Familial Mediterranean Fever Diagnosis and Treatment. J Rheumatol-Special 10:46–54 (Turkiye Klinikleri)
Üstebay S, Üstebay DÜ, Yılmaz Y (2015) Familial Mediterranean fever. JAREM 5:89–93
Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885
Yılmaz E, Dinçel N, Sözeri B, Özdemir K, Bulut İ, Berdelı A, Mir M (2015) Familial Mediterranean fever in children from the Aegean region of Turkey: gene mutation frequencies and phenotype-genotype correlation. Turk J Med Sci 45:1198–1206
Pras E, Livneh A, Balow JE Jr, Pras E, Kastner DL, Pras M, Langevitz P (1998) Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet 13(75):216–219
Soylemezoglu O, Kandur Y, Gonen S, Düzova A, Özçakar ZB, Fidan K, Yalcinkaya F (2016) Familial Mediterranean fever gene mutation frequencies in a sample Turkish population. Clin Exp Rheumatol 34:97–100
Coşkun S, Kurtgöz S, Keskin E, Sönmez F, Bozkurt G (2015) Frequency of mutations in Mediterranean fever gene, with gender and genotype-phenotype correlations in a Turkish population. J Genet 94:629–635
Ben-Chetrit E, Touitou I (2009) Familial mediterranean Fever in the world. Arthritis Rheum 61:1447–1453
Yavuz S, Selçuk Duru N, Elevli M (2018) Ailevi Akdeniz Ateşi hastalarında klinik, laboratuar Bulguları, Hastalık ağırlık skorları ve Gen Mutasyonları Arasındaki İlişki. Med Bull Haseki 56:58–64
Çobankara V, Balkarlı A (2011) Familial Mediterranean Fever. Pam Tıp Derg 4:86–98
Kişla Ekinci RM, Balci S, Ufuk Altintaş D, Yilmaz M (2017) The influence of concomitant disorders on disease severity of familial mediterranean fever in children. Arch Rheumatol 33:282–287
Akar S, Soysal O, Balci A, Solmaz D, Gerdan V, Onen F, Tunca M, Akkoc N (2013) High prevalence of spondyloarthritis and ankylosing spondylitis among familial Mediterraneanfever patients and their first-degree relatives: further evidence for the connection. Arthritis Res Ther. https://doi.org/10.1186/ar4154
Onen F, Solmaz D, Cetin P, Balci A, Akar S, Akkoc N (2013) Prevelance of inflammatory back pain and axial spondyloarthritis among university employees In Izmir, Turkey. Arthritis Rheum 65(1054–5):5
Ben-Chetrit E, Levy M (2003) Reproductive system in familial Mediterranean fever: an overview. Ann Rheum Dis 62:916–919
Ben-Chetrit E, Ben-Chetrit A, Berkun Y, Ben-Chetrit E (2010) Pregnancy outcomes in women with familial Mediterranean fever receiving colchicine: is amniocentesis justified? Arthritis Care Res 62:143–148
Ben-Chetrit E (2018) Management of familial Mediterranean fever. https://www.uptodate.com/contents/management-of-familial-mediterranean-fever. Accessed 4 Nov 2018
Praveen L, Sohaib I, Divya V, Gurram Richard O (2018) Day use of colchicine in pregnancy: a systematic review and meta- analysis. Rheumatology 57:382–387
Yazıcıoğlu A, Turgal M, Yücel ÖS, Özyüncü Ö, Beksaç MS (2014) Pregnancy outcome in women with familial Mediterranean fever: a retrospective analysis of 50 cases with a 10-year experience. Arch Rheumatol 29:94–98
Gümüş E (2018) The frequency of MEFV gene mutations and genotypes in Sanliurfa Province, South-Eastern Region of Turkey, after the Syrian Civil War by using next generation sequencing and report of a Novel Exon 4 Mutation (I423T). J Clin Med. https://doi.org/10.3390/jcm7050105
Pasa S, Altıntas A, Devecioglu B, Cil T, Danış R, Isı H, Bayan K, Tuzun Y, Ecer S, Batun S, Ayyıldız O (2008) Familial Mediterranean fever gene mutations in the Southeastern region of Turkey and their phenotypical features. Amyloid 15:49–53
Atagunduza MP, Tuglularb S, Kantarcic G, Akoglub E, Direskenelia H (2004) Association of FMF-related (MEFV) point mutations with secondary and FMF amyloidosis. Nephron Clin Pract 96:131–135
Üreten K, Gönülalan G, Akbal E, Güneo F, Akyürek Ö, Özbek M, Öztürk MA (2010) Demographic, clinical and mutational characteristics of Turkish familial Mediterranean fever patients: results of a single center in Central Anatolia. Rheumatol Int 30:911–915
Akse-Önal V, Sağ E, Ozen S, Bakkaloglu A, Cakar N, Besbas N, Gucer S (2010) Decrease in the rate of secondary amyloidosis in Turkish children with FMF: are we doing better? Eur J Pediatr 169:971–974
Topaloglu R, Ozaltin F, Yilmaz E, Ozen S, Balci B, Besbas N, Bakkaloglu A (2005) E148Q is a disease-causing MEFV mutation: a phenotypic evaluation in patients with familial Mediterranean fever. Ann Rheum Dis 64:750–752
Marek-Yagel D, Bar-Joseph I, Pras E, Berkun Y (2009) Is E148Q a benign polymorphism or a disease-causing mutation? J Rheumatol 36:2372–2373
Bakan A, Oral A, Alışır Ecder S, Şaşak Kuzgun G, Elçioğlu ÖC, Demirci R, Aydın Bahat K, Odabas AR (2019) Assessment of mean platelet volume in patients with AA amyloidosis and AA amyloidosis secondary to familial Mediterranean fever: a retrospective chart: review study. Med Sci Monit 24:3854–3859
Nobakht H, Zamani F, Ajdarkosh H, Mohamadzadeh Z, Fereshtehnejad S, Nassaji M (2011) Adult- onset familial Mediterranean fever in Northwestern Iran; clinical feature and treatment outcome. Middle East J Dig Dis 3:50–55
Sayaliolu M, Cefle A, İnanç M, Kamali S, Dalkılıç E, Gul A, Ocal L, Aral O, Konice M (2005) Characteristics of patients with adult-onset familial Mediterranean fever in Turkey: analysis of 401 cases. Int J Clin Pract 59:202–205
Acknowledgements
The authors would like to thank Enago (www.enago.com) for English language review.
Funding
This study was not funded.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Author Hatice Bodur, Fatma Gül Yurdakul Hasan Fatih Çay Ülkü Uçar Yaşar Keskin Betül Sargınn Gülcan Gürer Ozan Volkan Yurdakul Mustafa Çalış Hülya Deveci Yıldıray Aydın Sami Hizmetli Remzi Çevik Ali Yavuz Karahan İsmihan Sunar Mehmet Tuncay Duruöz Hilal Ecesoy Zafer Günendi Murat Toprak Nesrin Şen Duygu Altıntaş Ahmet Kıvanç Cengiz Gökhan Çağlayan Ali Nail Demir Hüseyin Kaplan Sertaç Ketenci Meltem Alkan Melikoğlu Mehmet Nayimoğlu Kemal Nas Ayşe Banu Sarıfakıoğlu and İlhan Sezer declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards (ethic committee approval date/no:22.11.2107/E-17-1626).
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bodur, H., Yurdakul, F.G., Çay, H.F. et al. Familial mediterranean fever: assessment of clinical manifestations, pregnancy, genetic mutational analyses, and disease severity in a national cohort. Rheumatol Int 40, 29–40 (2020). https://doi.org/10.1007/s00296-019-04443-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-019-04443-0